Tenaya Therapeutics (TNYA) traded up 0.26 % during a 24 hours period ending at 07:22 PM Central Europe on Monday 26th. One Tenaya Therapeutics stock can currently be bought for about USD 0.42 on popular exchanges. Current supply of Tenaya Therapeutics stocks is 224.2 mn. Tenaya Therapeutics has a current market capitalization of USD 87.2 mn and approximately USD 654.9 k worth of Tenaya Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Tenaya Therapeutics has traded -37.26 % down. Simple moving average of last 200 days is at USD 0.72. The highest price of past 52 weeks was recorded at USD 1.65 on 10/28/2025. 52 weeks low was at USD 0.36 on 10/14/2026.

Here is how related stocks have performed in the past 24 hours:

  • Anixa Biosciences (ANIX) traded up 7.55 % and now trades at USD 2.94. Anixa Biosciences has a market capitalisation of USD 103.9 mn.

  • Wisesat Space (SAIQ) traded up 15.91 % and now trades at USD 6.92. Current market capitalisation for Wisesat Space is USD 102.9 mn.

  • East West Ave Acquisition (EWAVU) traded down -0.1 % and now trades at USD 10.03. Current market capitalisation for East West Ave Acquisition is USD 103.5 mn.

  • Tevogen (TVGN) traded down -4.11 % and now trades at USD 6.36. Tevogen has a market capitalisation of USD 102.8 mn.

  • Lifemd (LFMD) traded down -1.84 % and now trades at USD 2.11. Current market capitalisation for Lifemd is USD 102.7 mn. LifeMD Inc. is scheduled to present its latest quarterly results at the upcoming financial conference on 9 November. Analysts anticipate a modest decline in earnings per share compared to the prior year, with projections indicating a slightly larger loss per share for the quarter. Revenue forecasts for the most recent quarter suggest a noticeable drop relative to the same period last year, while expectations for the full fiscal year point to a continued decline in earnings per share. However, revenue outlooks for the year are projected to rise compared to the previous year, reflecting a broader growth trend in the company’s top‑line performance. The company’s forthcoming report is expected to provide further clarity on its financial trajectory amid the current market environment.

About Tenaya Therapeutics

The biotechnology company Tenaya Therapeutics, Inc. is located in San Francisco, United States. Their mission is to discover, develop, and deliver curative therapies that target the underlying factors of heart disease. By addressing these root causes, Tenaya Therapeutics strives to improve patient outcomes and overall health in the United States. You can learn more about their work and offerings by visiting their website at www.tenayatherapeutics.com . They are Nasdaq-listed.